Skip to main content
OpenTrials
Completed

NCT Number: NCT02419794

Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism (RESCUE)-Japan Registry 2

The aim of this study is to clarify treatment status and clinical results of acute cerebral ischemia after approval of clot retriever in Japan, and also to obtain a basis for comparative studies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ischemic Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Stroke Vascular Diseases

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hyogo College of Medicine

Nishinomiya, Hyōgo, 663-8501, Japan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients admitted from Oct. 1st 2014 to Sep. 30st 2016.
  • Patients who were 20 years and older admitted within 24 hours after onset.
  • The patients with large vessel occlusion (ICA, MCA, VA, BA, PCA).
  • Patients who did not fulfill the criteria of RESCUE-Japan RCT.

Exclusion criteria

･Patients who are considered inappropriate to participate in the study are excluded.

Treatment and study plan

endovascular treatment

Procedure

endovascular treatment for acute ischemic stroke patients with large vessel occlusion

Primary outcomes

  1. modified Rankin Scale (mRS) of 0-2 at 90 days (+/- 10 days) after onset

    Time frame: 90 days

Secondary outcomes

  1. Death within 90 days (+/- 10 day) after the onset

    Time frame: 90 days

  2. modified Rankin Scale (mRS) of 0-1 at 90 days (+/- 10 days) after onset

    Time frame: 90 days

  3. All bleeding within 90 days (+/- 10 days) after onset

    Time frame: 90 days

  4. All intracranial hemorrhage within 90 days (+/- 10 days) after onset

    Time frame: 90 days

  5. Symptomatic intracranial hemorrhage within 90 days (+/- 10 days) after onset

    Time frame: 90 days

Other outcomes

  1. Symptomatic intracranial hemorrhage within 72 hours (+/- 8 hours) after onset

    Time frame: 72 hours

  2. Reccurrence of stroke within 90 days (+/- 10 days) after onset

    Time frame: 90 days

Sponsors and collaborators

Lead sponsor

Hyogo Medical University

Other

Registry information

Important dates

Study start
2014
Primary completion
2016
Study completion
2017
First posted
Apr 17, 2015
Registry last updated
Jul 21, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.